A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.
10.1016/j.ijid.2020.11.191
Saved in:
Main Authors: | Ahmed, Sabeena, Karim, Mohammad Mahbubul, Ross, Allen G, Hossain, Mohammad Sharif, Clemens, John D, Sumiya, Mariya Kibtiya, Phru, Ching Swe, Rahman, Mustafizur, Zaman, Khalequ, Somani, Jyoti, Yasmin, Rubina, Hasnat, Mohammad Abul, Kabir, Ahmedul, Aziz, Asma Binte, Khan, Wasif Ali |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206712 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by community and university campus wastewater surveillance
by: Chua, Desmond Feng Jun, et al.
Published: (2023) -
Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
by: Tan, Glorijoy Shi En, et al.
Published: (2023) -
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023) -
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
by: Poh, Xuan Ying, et al.
Published: (2023) -
Extrapulmonary manifestations and complications of severe acute respiratory syndrome coronavirus 2 infection: a systematic review.
by: Cho, Jiacai, et al.
Published: (2021)